RNDr. Pavel Krejčí, Ph.D.
Head of the research group, Pavel Krejčí Research Group
Office: bldg. C03/246
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5395 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 119
2013
-
The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration
Cancer Research, year: 2013, volume: 73, edition: 5, DOI
2012
-
Apoptosis inhibitor 5 (API-5; AAC-11; FIF) is upregulated in human carcinomas in vivo
Oncology Letters, year: 2012, volume: 3, edition: 4, DOI
-
Bent Bone Dysplasia-FGFR2 type, a Distinct Skeletal Disorder, Has Deficient Canonical FGF Signaling
The American Journal of Human Genetics, year: 2012, volume: 90, edition: 3, DOI
-
Exome Sequencing Identifies PDE4D mutations in Acrodysostosis
The American Journal of Human Genetics, year: 2012, volume: 90, edition: 4, DOI
-
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
The journal of clinical investigation, year: 2012, volume: 122, edition: 6, DOI
-
Receptor tyrosine kinases activate canonical WNT/beta catenin signaling via MAP kinase/LRP6 pathway and direct beta-Catenin phosphorylation
Plos One, year: 2012, volume: 7, edition: 4, DOI
-
Sixteen years and counting: the current understanding of fibroblast growth factorreceptor 3 (FGFR3) signaling in skeletal dysplasias.
Human Mutation, year: 2012, volume: 33, edition: 1, DOI
-
Způsob stanovení závažnosti a prognózy B-buněčné chronické lymfocytární leukémie
Publisher: , state: Czech Republic, patent's number: 303555, year: 2012
2011
-
Mitogen-Activated Protein Kinases Promote WNT/beta-Catenin Signaling via Phosphorylation of LRP6
Molecular and cellular biology, year: 2011, volume: 31, edition: 1, DOI
-
Post-translational modifications regulate signalling by Ror1
Acta Physiologica, year: 2011, volume: 203, edition: 3, DOI